Cargando…
Increasing the Therapeutic Efficacy of Extracellular Vesicles From the Antigen-Specific Antibody and Light Chain Perspective
Due to their exceptional properties, extracellular vesicles (EVs) receive special attention as next generation biotherapeutics and vehicles for drug delivery. However, despite having many advantages over cell-based therapies, EVs usually exert lower therapeutic efficacy. This results from a number o...
Autores principales: | Nazimek, Katarzyna, Bryniarski, Krzysztof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652241/ https://www.ncbi.nlm.nih.gov/pubmed/34901032 http://dx.doi.org/10.3389/fcell.2021.790722 |
Ejemplares similares
-
Biodelivery of therapeutic extracellular vesicles: should mononuclear phagocytes always be feared?
por: Cieślik, Martyna, et al.
Publicado: (2023) -
Editorial: Extracellular vesicles as potent modulators of immunity
por: Bryniarski, Krzysztof, et al.
Publicado: (2023) -
Extracellular Vesicles—Oral Therapeutics of the Future
por: Cieślik, Martyna, et al.
Publicado: (2022) -
Advances in the Current Understanding of the Role of Extracellular Vesicles in Allergy, Autoimmunity and Immune Regulation
por: Bryniarski, Krzysztof, et al.
Publicado: (2022) -
Antibody Light Chains Dictate the Specificity of Contact Hypersensitivity Effector Cell Suppression Mediated by Exosomes
por: Nazimek, Katarzyna, et al.
Publicado: (2018)